miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technology in Cancer Research & Treatment · 2023
DOI: 10.1177/15330338231218218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Hongchao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Yiluo Hospital of Luoyang, The Teaching Hospital of Henan University of Science and Technology, Luoyang, China. Hauptthemen laut MEDLINE: MicroRNAs, Glioblastoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Science and Technology Program of Henan Province, Medical Key Cultivation Discipline Program of Luoyang City, Science and Technology Development Project of Luoyang City.
Abstract (Originalsprache)
Glioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma cell lines were detected by real-time quantitative polymerase chain reaction. Cell viability and migration were detected by methylthiazolyl tetrazolium assay and transwell assay, and cell cycle analysis was detected by flow cytometry. The expression of CPEB4 protein and epithelial-mesenchymal transition associated markers were detected by western blot. Bioinformatics and luciferase activity analysis were used to verify the targeting relationship between miR-130a-3p and CPEB4. We observed that the expression of CPEB4 was upregulated while that of miR-130a-3p was downregulated in glioblastoma cell lines. CPEB4 was validated as a target of miR-130a-3p by luciferase activity assay. Increased levels of miR-130a-3p inhibited the proliferation and migration of the glioblastoma cells and the overexpression of miR-130a-3p inhibited epithelial-mesenchymal transition. However, CPEB4 overexpression resisted the inhibitory effects of miR-130a-3p. Our study elucidates CPEB4 is upregulated because of the downregulated miR-130a-3p in glioblastoma, which enhances the glioblastoma growth and migration, suggesting a potential therapeutic target for the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Yiluo Hospital of Luoyang, The Teaching Hospital of Henan University of Science and Technology, Luoyang, China.
ORCID-Profile: Hongchao Liu
Förderung
- Medical Science and Technology Program of Henan Province
- Medical Key Cultivation Discipline Program of Luoyang City
- Science and Technology Development Project of Luoyang City
Zitieren
APA
Liu, H., Wei, Z., Shi, K., Zhang, Y., & Li, J. (2023). miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231218218
Vancouver
Liu H, Wei Z, Shi K, Zhang Y, Li J. miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231218218
BibTeX
@article{Liu2023,
author = {Liu, Hongchao and Wei, Zhihao and Shi, Kangke and Zhang, Yu and Li, Jiaqiong},
title = {miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression},
journal = {Technology in Cancer Research & Treatment},
year = {2023},
doi = {10.1177/15330338231218218}
}
EUVIMED